The future of vaccines is needle-free
Beyond sidestepping people’s fear of needles, these vaccines would also make it easier to store and distribute ahead of ...
CDC upgrades its advisory on bird flu. Will Moderna’s stock get a boost?
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?
The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.
Is Moderna a Bad-News Buy for 2025?
At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...
Northeast Ohio pediatrician’s office working with Moderna on a potential mono vaccine
The research team at Senders Pediatrics is working with Moderna to study a vaccine developed for Epstein-Barr Virus, which causes mono.
Moderna target nearly halved by Morgan Stanley on weak guidance
Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue guidance and ongoing competitive pressures in the vaccine market.
No Evidence Woman's Breasts Grew to Triple G-Cup After Receiving COVID-19 Vaccine
No scientific studies have established a causal relationship between the Pfizer vaccine and conditions that cause the excessive growth of breasts.